- Net Asset Value (NAV) increases to € 47.6 million as of June 30, 2023 (December 31, 2022: € 47.5 million)
- NAV per share slightly up to € 6.91 as of June 30, 2023
(December 31, 2022: € 6.89)
- Conversion of accounting standards to HGB / individual financial statements
- Significant earnings improvement in first half results of 2023 and further reduction in net financial liabilities to € 0.97 million
Munich, September 20, 2023 – Mountain Alliance AG (MA, ISIN DE000A12UK08) today published its half-year report 2023 as well as net asset value as of June 30, 2023. Beginning with the financial year 2023, Mountain Alliance AG will only prepare individual financial statements in accordance with the German Commercial Code (HGB) and no longer consolidated financial statements in accordance with International Financial Reporting Standards (IFRS) while at the same time implementing investor reporting as of the annual financial statements 2023. The main reason for this decision is the high cost of complying with IFRS accounting requirements.
Mountain Alliance AG continued to perform solidly in the first half of 2023 even though the prevailing economic sentiment remained subdued. From an operational perspective, Mountain Alliance AG is on a growth path at group level and is on track overall to achieve the annual targets for the development of net asset value in the current year as announced in the Annual Report 2022.
Mountain Alliance AG generated sales of € 63,833 in the first half of 2023, compared to € 27,900 in the previous year according to the German Commercial Code (HGB). Net loss for the first half of 2023 was € 584,659 compared to a loss of € 1,101,553 in the same period of the previous year.
Pro forma data on an IFRS basis for better comparability are as follows: in the first half of 2023, Mountain Alliance AG generated consolidated pro forma sales (IFRS) of € 5.9 million compared to € 5.7 million in the same period of the previous year.
The relevant pro forma financial result for the first half of the year 2023 improved significantly to € 1.99 million compared to minus € 1.75 million in the same period of the previous year, benefiting in particular from positive valuation effects at Lingoda. Pro forma earnings before tax (EBT) improved to € 1.44 million in the period under review, compared to minus € 2.32 million in the same period of the previous year, and pro forma net profit to € 0.98 million, compared to minus € 2.32 million in the first half of 2023. Pro forma earnings per Mountain Alliance share therefore stood at € 0.14 in the first half of 2023, compared to minus € 0.34 in the same period of the previous year.
For Mountain Alliance AG as a venture capital investment company, the development of the portfolio is the key target and control indicator. As of June 30, 2023, the portfolio value amounted to € 48.6 million, compared to € 49.3 million as of December 31, 2022. The moderate decrease is mainly due to the development and sale of listed investments that are no longer part of the core portfolio. Taking into account net financial liabilities of € 0.97 million, the NAV of Mountain Alliance AG amounted to € 47.6 million, compared to € 47.5 million at year-end 2022. The reduction in net financial liabilities to € 0.97 million (December 31, 2022: € 1.8 million) had a positive impact. Based on 6.886 million shares outstanding, the NAV per share is slightly higher at € 6.91 as of June 30, 2023, compared to € 6.89 as of December 31, 2022.
The investment portfolio has reached a certain maturity that will ensure a continuation of the successful exit activity of recent years. In this regard, great expectations are placed on the online language learning platform Lingoda, in which Mountain Alliance AG holds a stake of around 7%.
Looking ahead to the full year 2023 and beyond, the Management Board is optimistic given the foreseeable milestones, even though external conditions such as continued high inflation, the development of the war in Ukraine, rising market interest rates, and slowing economic momentum significantly limit the accuracy of the forecast. Provided there is no significant deterioration in these external factors, the Management Board believes that the previously communicated target for the full year 2023 is achievable, with an organic increase of 5%, starting from a net asset value in 2022 of € 47.5 million. This target remains subject to the future performance of the listed investments and based on the growth of the portfolio companies, increasing investor interest in portfolio investments and value-adding acquisitions.
"We are facing exciting times with our promising portfolio. From an exit perspective, the focus is primarily on our investments in AlphaPet and our largest asset by value, Lingoda," says Manfred Danner, CEO of Mountain Alliance AG.
The half-year report 2023 is available for download at www.mountain-alliance.de.
cialis 20 mg price
cialis 20 mg price
escitalopram vs alprazolam
escitalopram vs alprazolam
is 50mg of zoloft a high dose
is 50mg of zoloft a high dose
can i take cephalexin without food
can i take cephalexin without food
metronidazole definition
metronidazole definition
lexapro erectile dysfunction
lexapro erectile dysfunction
cymbalta controlled
cymbalta controlled
fluoxetine 60mg
fluoxetine 60mg
does keflex help with ear infection
does keflex help with ear infection
where can you buy viagra online safely
where can you buy viagra online safely
gabapentin halsschmerzen
gabapentin halsschmerzen
duloxetine peripheral neuropathy
duloxetine peripheral neuropathy
azithromycin 10 days
azithromycin 10 days
ciprofloxacin strep throat
ciprofloxacin strep throat
cephalexin pregnancy category
cephalexin pregnancy category
bactrim antibiotic side effects
bactrim antibiotic side effects
can you eat ice cream while taking bactrim
can you eat ice cream while taking bactrim
buspar and neurontin
buspar and neurontin
amoxicillin dosage for adults
amoxicillin dosage for adults
is cozaar an ace inhibitor
is cozaar an ace inhibitor
depakote sprinkles 125 mg
depakote sprinkles 125 mg
how long does it take effexor to work
how long does it take effexor to work
how does flexeril work
how does flexeril work
flomax per dolori mestruali
flomax per dolori mestruali
diltiazem 24hr er 180 mg cap
diltiazem 24hr er 180 mg cap
ezetimibe action mechanism
ezetimibe action mechanism
diclofenac sodium dosage
diclofenac sodium dosage
amoxicillin augmentin
amoxicillin augmentin
goodrx contrave
goodrx contrave
is escitaloprám the same as citalopram
is escitaloprám the same as citalopram
ddavp pills not working
ddavp pills not working
what are the side effects of aripiprazole
what are the side effects of aripiprazole
what is allopurinol used to treat
what is allopurinol used to treat
side effects of amitriptyline
side effects of amitriptyline
is aspirin a blood thinner
is aspirin a blood thinner
how long does baclofen stay in your system
how long does baclofen stay in your system
celebrex 200 mg capsule
celebrex 200 mg capsule
ashwagandha negative side effects
ashwagandha negative side effects
buspar withdrawal symptoms
buspar withdrawal symptoms
what is celecoxib capsules 200mg
what is celecoxib capsules 200mg
difference between amoxicillin and augmentin
difference between amoxicillin and augmentin
protonix dosage 80 mg
protonix dosage 80 mg
coming off remeron
coming off remeron
abilify 5 mg
abilify 5 mg
actos swissmedic
actos swissmedic
does semaglutide need to be refrigerated
does semaglutide need to be refrigerated
can robaxin cause constipation
can robaxin cause constipation
prandin repaglinide tablets
prandin repaglinide tablets
acarbose indikation
acarbose indikation
tizanidine side effects weight loss
tizanidine side effects weight loss
cost of voltaren gel 1%
cost of voltaren gel 1%
spironolactone 90 day supply
spironolactone 90 day supply
sandoz-tamsulosin 0.4mg
sandoz-tamsulosin 0.4mg
venlafaxine dosing
venlafaxine dosing
synthroid aspirin
synthroid aspirin
maximum dose of sitagliptin
maximum dose of sitagliptin
cost of stromectol medication
cost of stromectol medication
maryland board of pharmacy
maryland board of pharmacy
cialis online pills
cialis online pills
tramadol us pharmacy overnight
tramadol us pharmacy overnight
hims sildenafil review
hims sildenafil review
where to buy levitra online no prescription
where to buy levitra online no prescription
sildenafil 20 mg not working
sildenafil 20 mg not working
tadalafil tablets 20 mg global
tadalafil tablets 20 mg global
cheapest generic levitra
cheapest generic levitra
what is vardenafil 20 mg
what is vardenafil 20 mg
usa viagra over the counter
usa viagra over the counter
difference between sildenafil tadalafil and vardenafil
difference between sildenafil tadalafil and vardenafil
online viagra canadian pharmacy online
online viagra canadian pharmacy online
ivermectin pill cost
ivermectin pill cost
stromectol oral
stromectol oral
ivermectin 18mg
ivermectin 18mg
ivermectin for sale
ivermectin for sale
mantra 10 tadalafil tablets
mantra 10 tadalafil tablets
price of stromectol
price of stromectol
how to buy stromectol
how to buy stromectol
vardenafil tadalafil sildenafil
vardenafil tadalafil sildenafil
solumedrol to prednisone
solumedrol to prednisone
gabapentin maximum dosage for sleep
gabapentin maximum dosage for sleep
[augmentin].
[augmentin].
what does metronidazole treat in dogs
what does metronidazole treat in dogs
does lisinopril cause hair loss
does lisinopril cause hair loss
nursing interventions for ampicillin
nursing interventions for ampicillin
drinking on doxycycline
drinking on doxycycline
amoxicillin vs cephalexin
amoxicillin vs cephalexin
gebelik glucophage
gebelik glucophage
modafinil and provigil
modafinil and provigil
is keflex a penicillin
is keflex a penicillin
how long for amoxicillin to work
how long for amoxicillin to work
how long does pregabalin take to kick in
how long does pregabalin take to kick in
do trazodone side effects go away
do trazodone side effects go away
antibiotic ciprofloxacin
antibiotic ciprofloxacin
valtrex price
valtrex price
tamoxifen brain fog
tamoxifen brain fog